Related Experiment Video
Updated: May 27, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Association Between Elevated Total Homocysteine and Heart Failure Risk in the Multi-Ethnic Study of Atherosclerosis
Amy B Karger1, Sarah O Nomura1, Weihua Guan2
1Department of Laboratory Medicine & Pathology University of Minnesota Minneapolis MN USA.
Insights
Elevated total homocysteine (tHcy) is linked to heart failure (HF) risk, particularly HF with preserved ejection fraction (HFpEF). The study highlights differing impacts of tHcy and dysglycemia on HF subtypes.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Epidemiology
Background:
- Limited research links elevated total homocysteine (tHcy) to heart failure (HF) risk.
- No studies have investigated if this association varies by HF subtype (HFpEF, HFrEF).
Purpose of the Study:
- To examine the relationship between tHcy and the risk of overall HF, HFpEF, and HFrEF.
- To assess if the impact of tHcy on HF risk differs by HF subtype.
- To investigate the combined effects of elevated tHcy and dysglycemia on HF incidence.
Main Methods:
- Utilized data from 6765 participants in the Multi-Ethnic Study of Atherosclerosis with baseline tHcy and HF data.
- Employed Cox proportional hazards regression to calculate hazard ratios for tHcy and HF risk.
- Stratified models by impaired fasting glucose/type 2 diabetes status to examine combined impacts.
Main Results:
- Elevated tHcy (>12 micromol/L) was significantly associated with overall HF and HFpEF.
- Individuals with both elevated tHcy and dysglycemia showed increased risk for overall HF and HFrEF, with a trend for HFpEF.
- tHcy was a stronger contributor to HFpEF risk, while dysglycemia was more critical for HFrEF risk.
Conclusions:
- Confirms the association between hyperhomocysteinemia and HF risk in a large, multi-ethnic cohort.
- First study to show that tHcy's impact on HF risk differs by subtype.
- tHcy appears to contribute more significantly to HFpEF risk than HFrEF risk.
Background:
Limited studies show an association between elevated total homocysteine (tHcy) and heart failure (HF) risk, but no studies have assessed whether this association differs by HF subtype. This study examines the relationship between tHcy, HF overall, and HF subtype (HF with preserved ejection fraction [HFpEF] and HF with reduced ejection fraction) in the Multi-Ethnic Study of Atherosclerosis cohort.
Methods:
Multi-Ethnic Study of Atherosclerosis participants with baseline tHcy and HF data were included (N=6765). Cox proportional hazards regression was used to calculate hazard ratios and 95% CI for tHcy and risk of HF. Models were stratified by impaired fasting glucose/type 2 diabetes status, and the combined impact of elevated tHcy and impaired fasting glucose/type 2 diabetes on HF incidence was examined.
Results:
Elevated tHcy (>12 μmol/L) was statistically significantly associated with HF overall and HFpEF, and conferred a higher risk for HF overall among individuals with dysglycemia impaired fasting glucose/type 2 diabetes compared with those with normoglycemia. Additionally, there was a statistically significant increased risk of HF overall and HF with reduced ejection fraction and a trend towards increased risk of HFpEF in individuals with both elevated tHcy and dysglycemia. tHcy appears to be a more significant contributor to HFpEF risk than dysglycemia, whereas dysglycemia seems to be more important in driving HF with reduced ejection fraction risk.
Conclusions:
Our study confirms an association between hyperhomocysteinemia and HF risk in a large, multi-ethnic cohort. This is the first study to demonstrate that the impact of tHcy differs by HF subtype and appears to contribute more to HFpEF risk than HF with reduced ejection fraction risk.
More Related Videos
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Pathophysiology of Heart Failure
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...